期刊文献+

Toll样受体9与消化系统疾病的相关研究进展 被引量:1

Research Progress in Toll Like Receptor 9 and Its Effect on Digestive System Disease
下载PDF
导出
摘要 Toll样受体(TLRs)是广泛表达于哺乳动物细胞的跨膜受体,是机体抵抗外界病原微生物入侵的屏障,也是天然免疫应答与获得免疫应答的桥梁。TLR9为TLRs成员之一,在机体产生炎症和肿瘤时表达明显增加,与炎症的严重程度及肿瘤的恶性程度有一定的相关性。TLR9模式识别外来病原体和机体产生的一些自身物质,进而激活髓系分化蛋白88依赖性信号通路,使机体产生免疫应答而参与炎症和肿瘤的发生、发展。所以,TLR9有可能成为新的治疗靶点以控制炎症和肿瘤的发展。 Toll like receptors( TLRs) are transmembrane receptors which express widely in cells of mammals. They are barriers for protecting the body from pathogenic microorganism invading,and also the connection of innate immune response and adaptive immune response. TLR9 is a member of TLRs. The expression of TLR9 is significantly increased when there is inflammation or tumor in vivo. The TLR9 expression level has a certain degree of correlation with the severity of inflammation and malignant tumors. TLR9 pattern recognizes the foreign pathogens and someself-generated substance,and then activates myeloid differentiation primary response protein 88-dependent signaling pathway,enabling the body to produce an immune response and to participate in the development of inflammation and tumors. Therefore,TLR9 may become a new therapeutic target to control inflammation and tumor development.
作者 张露 唐国都
出处 《医学综述》 2014年第22期4036-4038,共3页 Medical Recapitulate
基金 国家自然科学基金资助项目(81060043) 广西研究生教育创新计划资助项目(YCSZ2013034)
关键词 TOLL样受体9 消化系统疾病 炎症 肿瘤 Toll like receptors 9 Digestive system disease Inflammation Tumor
  • 相关文献

参考文献5

二级参考文献48

  • 1KM Lammers,S Ouburg,SA Morré,JBA Crusius,P Gionchetti,F Rizzello,C Morselli,E Caramelli,R Conte,G Poggioli,M Campieri,AS Pea.Combined carriership of TLR9 -1237C and CD14 -260T alleles enhances the risk of developing chronic relapsing pouchitis[J].World Journal of Gastroenterology,2005,11(46):7323-7329. 被引量:7
  • 2陈胜,邹开芳,杨天,谭琰,丁炎波,钱伟.Toll样受体(TLR)2、TLR4和TLR9在大鼠结肠炎模型结肠组织中的表达及其意义[J].胃肠病学,2007,12(6):339-343. 被引量:25
  • 3江学良 权启镇 等.复合法建立大鼠溃疡性结肠炎模型及其免疫和超微结构变化[J].世界华人消化杂志,1999,7:381-381.
  • 4Duan XZ, Wang M, Li HW, et al. Decreased frequency and function of circulating plasmocytoid dendritic cells(pDC) in hepatitis B virus infected humans. J Clin Immunol, 2004, 24:637-646.
  • 5Latz E, Schoenemeyer A, Visintin A, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol, 2004, 5:190-198.
  • 6McKenna K, Beignon AS, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol, 2005,79:17-27.
  • 7Sweet MJ, Campbell CC, Sester DP, et al. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J Immunol, 2002, 168:392-399.
  • 8Gerosa F, Baldani-Guerra B, Nisii C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med, 2002, 195:327-333.
  • 9Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynueleotides. J Immunol, 2002, 168:4531-4537.
  • 10Krug A, Luker GD, Barchet W, et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood, 2004, 103 : 1433-1437.

共引文献25

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部